Intervention The control group stopped taking warfarin 2 days before extraction if the INR was 42 and the procedure was rebooked for following day. The intervention group continued to take medication. If the INR was 44 on the day of the procedure the patient was withdrawn. The use of tranexamic acid mouth-rinse was not permitted. Extractions were performed under local anaesthetic using as atraumatic a technique as possible.
Outcome measure Clinical notes and patient logbooks were used to record any complications.
Results
The rate of bleeding complications was higher in the group continuing with anticoagulation but the difference was not significant.
Conclusions
The study shows that dental extractions can be carried out safely in a hospital without stopping anticoagulation if the patient's INR is 54.1.
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Commentary
In dentoalveolar surgery, the management of the anticoagulated patient is varied, controversial and, frequently, anecdote-based. The crux of the issue is whether to alter perioperative dosing of warfarin sodium for the subject undergoing dentoalveolar procedures. Some practitioners recommend discontinuing warfarin for 2 or more days before the procedure, whereas others recommend discontinuing warfarin and starting heparin and, finally, others support maintaining warfarin therapy during the perioperative regimen.
Regarding dental extractions, the management decision must balance the risk of developing an embolus when the warfarin is discontinued perioperatively versus the risk of significant bleeding following dental extractions if warfarin therapy is maintained perioperatively. Fortunately, there is a growing body of data providing evidence-based support regarding the perioperative management of anticoagulated patients who need tooth extractions. Specifically, the weight of the evidence supports the strategy of not altering perioperative dosing of warfarin when extracting teeth. In the final analysis, regardless of how the warfarin is managed, the overwhelming majority of patients will do well. If warfarin is discontinued perioperatively, there is a risk of a significant complication, an embolus, with an associated increased risk for death. The risk of an embolic episode if perioperative warfarin is discontinued for dental extractions was estimated to range between 3884 and 30 414 patients treated per embolic episode. 1 There is a low but finite risk of death, ie, major complication, if warfarin is discontinued. If warfarin is maintained, there is an increased risk for bleeding, but there are no reports of death, and managing the complication reaches the level of nuisance.
